Is Alpha-Arbutin safe in cosmetics?
Alpha-Arbutin has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
INCI: ALPHA-ARBUTIN
Alpha-Arbutin (CAS 84380-01-8) is a cosmetic active ingredient functioning as Tyrosinase inhibitor; synthetic alpha-enantiomer of arbutin; approximately 10x. Reported NOAEL =15 mg/kg/day in rat (SCCS_vision_codex); EU Regulation 1223/2009 status: restricted, max 2% face / 0.5% body. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in pharmaceutical data.
View industrial chemical safety profile for CAS 84380-01-8 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Alpha-Arbutin.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Alpha-Arbutin. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =15 mg/kg/day | oral | rat | reproductive toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw | oral | - | carcinogenicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw/d | - | - | repeated dose toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | reproductive toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw | oral | - | carcinogenicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | reproductive toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw | oral | - | carcinogenicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw/d | - | - | repeated dose toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg bw/d | - | - | repeated dose toxicity | SCCS_vision_codex |
| NOAEL | =15 mg/kg/day | oral | rat | reproductive toxicity | SCCS_vision_codex |
NOAEL/LOAEL values cited in official SCCS opinions for Alpha-Arbutin.
| NOAEL | LOAEL | Route | Species | Study | DA% (SCCS) | Opinion |
|---|---|---|---|---|---|---|
| 200 mg/kg/day | - | Oral | Rat | Subchronic (90-day) (90 days) | 10 | SCCS/1642/22 (2023) |
Skin absorption and penetration characteristics of Alpha-Arbutin, relevant to systemic exposure and MoS calculations.
Source: J Dermatol Sci 2005
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
agonist (ER, indirect via HQ metabolism)
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| AU | therapeutic_good | 5.0 | skin lightening |
| GCC | banned | - | Skin lightening products |
| UK | restricted | - | - |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 0.27 | In vitro; dermatomed human skin | Dermatomed human skin | SCCS/1552/15; SCCS/1642/22 (2022) |
| measured_sccs_opinion | 0.53% | - | - | SCCS/1552/15 |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Serum | 0.5–2 | 4 | CIR/SCCS |
| Face Cream | 0.5–2 | 4 | CIR/SCCS |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Alpha-Arbutin.
Public NOAEL study rows linked to Alpha-Arbutin by CAS number or substance name.
Units vary across source rows: mg/kg/day, mg/kg bw/day, mg/kg bw
| Absorption % | Method | Vehicle |
|---|---|---|
| 0.27 | In vitro; dermatomed human skin | Cream vehicle |
| 0.53% | SCCS opinion extraction | - |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Alpha-Arbutin has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Alpha-Arbutin EU regulatory status: restricted. Maximum allowed concentration: 2% face / 0.5% body. This is based on EU Regulation 1223/2009 and its amendments.
Alpha-Arbutin functions as: Tyrosinase inhibitor; synthetic alpha-enantiomer of arbutin; approximately 10x stronger tyrosinase inhibition than beta-arbutin at equivalent concentrations; reversible competitive inhibition at L-DOPA binding site. It is classified as a Active Ingredient in our database. CAS number: 84380-01-8.
The NOAEL (No Observed Adverse Effect Level) for Alpha-Arbutin is =15 mg/kg/day based on a reproductive toxicity study via oral route in rat. A total of 10 study endpoints are available. Source: SCCS_vision_codex.
Alpha-Arbutin also appears in pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Alpha-Arbutin compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Alpha-Arbutin in your formulation.